BioPharma Pharma Research

Analysis of DNA reveals weapons used by our immune cells to fight Tuberculosis

The team used high-throughput genomic technologies to learn how the DNA packaging inblood cells changes when a person has active TB, a bacterial disease th...

 February 17, 2022 | News

Biotium announces optimised antibody labeling kits for super-resolution microscopy

Biotium, a supplier of cutting-edge life science reagents, is expanding their line of industry-leading Mix-n-Stain™ labeling kits with new kits desig...

 February 16, 2022 | News

G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI

IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro&nb...

 February 15, 2022 | News

Kintor Pharma Announces First Patient Dosing in China

Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological th...

 February 14, 2022 | News

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

The state-of-the-art site marks a significant expansion of the company's advanced  protein and gene platforms, and is designed to provide high quality...

 February 10, 2022 | News

First Proton Therapy Treatment Delivered in Southeast Asia

The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...

 February 09, 2022 | News

Phenomenex Celebrates 40-Years of Keeping Scientists Happy & What's to Come

On this day in 1982, Phenomenex was born. Over the last four decades what started as a small idea in a garage has grown into a global corporation with more...

 February 04, 2022 | News

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

 February 04, 2022 | News

IsoPlexis opens first APAC office

IsoPlexis, the Superhuman Cell Company, today announced the opening of its first office in the Asia-Pacific (APAC) region headed by Jason Ou as President/G...

 February 03, 2022 | News

Reaction Biology Announces Integrated Drug Discovery Solution

The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...

 February 03, 2022 | News

BioMed X Institute and Merck KGaA, Extend Collaboration in Oncology

German independent research institute BioMed X announces today the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the res...

 February 01, 2022 | News

Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa

In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...

 February 01, 2022 | News

BeiGene Announces Acceptance of Supplemental New Drug Application in China

BRUKINSA was granted its first breakthrough therapy designation in China with this application The application is supported by SEQUOIA trial results, whic...

 January 31, 2022 | News

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab

Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...

 January 28, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close